Regenerative medicine approaches for the treatment of peripheral nerve injuries: progress and challenges
Yang H., Bao Q., Gu X., Cong M.
Narrative Review, published in Regen Biomater (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Regen Biomater (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41858554
- PMCID
- PMC12998714
- DOI
- 10.1093/rb/rbag015
- Citations
- 1
Abstract (original English)
Peripheral nerve injury (PNI), a prevalent clinical disorder induced by trauma, immune diseases and genetic factors, can result in sensory, motor and autonomic dysfunction, with this dysfunction seriously compromising patients' quality of life. Although traditional treatment methods such as autologous nerve transplantation are the gold standard, there are limitations such as insufficient donors, poor repair effect of long segmental defects and low functional recovery rate. Effective repair after nerve injury is still a challenge in neurosurgery. Therefore, new strategies need to be found to treat peripheral nerve injuries. Regenerative medicine has attracted much attention as an effective alternative therapy to promote the repair and regeneration of damaged peripheral nerves. Regenerative medicine provides new ideas for breaking through the bottleneck of traditional treatment by integrating cutting-edge technologies such as cell therapy, tissue engineering and gene therapy. However, current regenerative medicine needs to overcome challenges such as efficacy stability, long-term safety and cost-effectiveness. In this review, we summarize the structure and function of peripheral nerves, the mechanism and classification of injury and the pathological progression of PNI. Importantly, regenerative medicine strategies for the treatment of PNI are emphasized, and the challenges and fu
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.